BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24021784)

  • 41. Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen-activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection.
    Zhang H; Yan X; Yang C; Zhan Q; Fu Y; Luo H; Luo H
    J Viral Hepat; 2020 Nov; 27(11):1138-1149. PubMed ID: 32559002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
    Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
    Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
    Feitelson MA; Duan LX
    Am J Pathol; 1997 Apr; 150(4):1141-57. PubMed ID: 9094970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
    Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive regression analysis of hepatitis B virus X antigen level and anti-HBx antibody titer in the sera of patients with HBV infection.
    Pál J; Nyárády Z; Marczinovits I; Pár A; Ali YS; Berencsi G; Kvell K; Németh P
    Pathol Oncol Res; 2006; 12(1):34-40. PubMed ID: 16554914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical efficacy of various antiviral-based strategies to treat chronic hepatitis patients with positivity for hepatitis B e antigen and rtN236T mutation].
    Yue W; Yuan H; Mao XR; Deng YD; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):184-8. PubMed ID: 23967738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of mutant p53 in chronic HBV infection and hepatocellular carcinoma].
    Chen Y; Tang ZY; Li J
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):184-7. PubMed ID: 7956695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody.
    Pál J; Somogyi C; Szmolenszky A A; Szekeres G; Sípos J; Hegedüs G; Martzinovits I; Molnár J; Németh P
    Pathol Oncol Res; 2001; 7(3):178-84. PubMed ID: 11692143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma.
    Wang M; Qiu N; Lu S; Xiu D; Yu J; Wang XT; Lu F; Li T; Liu X; Zhuang H
    J Med Virol; 2013 Feb; 85(2):219-27. PubMed ID: 23168998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
    Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
    J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma.
    Bayliss J; Lim L; Thompson AJ; Desmond P; Angus P; Locarnini S; Revill PA
    J Hepatol; 2013 Nov; 59(5):1022-8. PubMed ID: 23811301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues].
    Wang C; Wang W; Lu H
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
    Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
    Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
    Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
    J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B.
    Pan J; Duan LX; Sun BS; Feitelson MA
    J Gen Virol; 2001 Jan; 82(Pt 1):171-182. PubMed ID: 11125170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues.
    Qiu D; Chen J; Liu J; Luo Z; Jiang W; Huang J; Qiu Z; Yue W; Wu L
    Exp Biol Med (Maywood); 2017 May; 242(9):939-944. PubMed ID: 28440732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.